Yesterdays anouncement of no bank debt and 26mil cash position equates to 31cents a share in cash and puts KYC on a PE of 2! Gross undervaluation.Q
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%